Dyslipidemia and Coronary Heart Disease: Molecular, Clinical, and Epidemiological Studies
博士 === 國立臺灣大學 === 臨床醫學研究所 === 90 === 英文簡述(Summary) Dyslipidemia and ensuing atherosclerosis have been implicated in the pathophysiology of coronary heart disease (CHD). A number of prospective studies have established that the risk of cardiac morbidity and mortality is directly related to...
Main Authors: | Tzung-Dau Wang, 王宗道 |
---|---|
Other Authors: | Yuan-Teh Lee |
Format: | Others |
Language: | zh-TW |
Published: |
2002
|
Online Access: | http://ndltd.ncl.edu.tw/handle/23468702731565163695 |
Similar Items
-
Antioxidant effects of simvastatin in patients with coronary heart disease and dyslipidemia
by: N. E. Artamoshina, et al.
Published: (2012-12-01) -
Dyslipidemia: A Trigger for Coronary Heart Disease in Romanian Patients with Diabetes
by: Mihnea-Alexandru Găman, et al.
Published: (2020-05-01) -
Dyslipidemia correction with atorvastatin in patients with coronary heart disease and arterial hypertension
by: N. B. Amirov, et al.
Published: (1970-01-01) -
Management of Dyslipidemia in Women and Men with Coronary Heart Disease: Results from POLASPIRE Study
by: Małgorzata Setny, et al.
Published: (2021-06-01) -
Antioxidant status and lipid peroxidation in stable coronary heart disease patients with dyslipidemia
by: O. L. Belaya, et al.
Published: (2006-10-01)